Sarepta Therapeutics note 1.500% 11/1 shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Sarepta Therapeutics note 1.500% 11/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics note 1.500% 11/1 held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.5k | 2.0k | 1.75 |
| 2023-06-30 | $1.0M | 601k | 1.69 |
| 2022-06-30 | $1.3M | 1.0M | 1.26 |
| 2021-12-31 | $450k | 307k | 1.47 |
| 2021-03-31 | $2.6M | 2.0M | 1.31 |
| 2020-12-31 | $1.7M | 685k | 2.44 |
| 2020-09-30 | $1.1M | 535k | 2.08 |
| 2020-06-30 | $483k | 210k | 2.30 |
| 2020-03-31 | $1.4M | 968k | 1.48 |
| 2019-12-31 | $11M | 5.5M | 1.94 |
| 2019-09-30 | $660k | 500k | 1.32 |
| 2019-06-30 | $193k | 99k | 1.95 |
| 2019-03-31 | $668k | 375k | 1.78 |
Top funds holding Sarepta Therapeutics note 1.500% 11/1
View all funds holding Sarepta Therapeutics note 1.500% 11/1